- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02530216
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes (AEGIS)
Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes
Healthcare delivery now mandates shorter visits with higher documentation requirements, undermining the patient-provider interaction. Electronic health records (EHRs) have the potential to improve outcomes and quality of care in this pressured environment, and are endorsed by the Patient Protection and Affordable Care Act (ACA) and Health Information Technology for Economic and Clinical Health (HITECH) Act as an important mechanism to support value-based healthcare. However, EHR systems were principally designed to support the transactional needs of administrators and billers, less so to nurture the relationship between patients and their providers. The purpose of this research is to identify ways to use EHRs to support clinical gastroenterologists and their patients while meeting the meaningful use requirements of the HITECH Act.
To improve clinic visit efficiency and meet criteria for meaningful use, investigators developed a patient-provider portal (P3) that systematically collects patient symptoms using a computer algorithm called Automated Evaluation of Gastrointestinal Symptoms (AEGIS). AEGIS utilizes computerized adaptive testing (CAT) to guide patients through questions drawn from a library of over 300 symptom attributes measuring the timing, severity, frequency, location, quality, and character of their GI symptoms, along with relevant comorbidities, family history, and alarm features. The system then automatically "translates" the patient report into a full narrative HPI available for use by GI providers in an EHR.
In a cross-sectional study in the American Journal of Gastroenterology comparing AEGIS versus physician-documented HPIs, investigators found that blinded physician reviewers perceived that AEGIS HPIs were of higher overall quality, better organized, and more succinct, comprehensible, complete and useful compared to HPIs written by physicians during usual care in academic GI clinics. In the current study, investigators aim to evaluate computer-generated HPIs prospectively on a wider scale in diverse academic and community-based settings. Moreover, investigators aim to test an enhanced AEGIS intervention that ties patient HPIs to an individualized "education prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presenting to the gastrointestinal clinic for evaluation.
- Able to read and write English.
- Has basic computing skills.
Exclusion Criteria:
- Having been seen and evaluated in the gastrointestinal clinic within the last 8 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care
Individuals in this arm will undergo usual care with their physician.
|
|
Experimental: AEGIS (Automated Evaluation of Gastrointestinal Symptoms)
Individuals in the AEGIS arm will be invited to use AEGIS/My GI Health prior to their clinic visit.
For those who complete AEGIS/My GI Health, their physician will have access to their AEGIS symptom report (includes a GI symptom heat map and GI history) and tailored education prescription.
|
AEGIS (Automated Evaluation of Gastrointestinal Symptoms) guides patients through questionnaires to measure symptom attributes including the timing, severity, frequency, location, quality, and character of their gastrointestinal (GI) symptoms, along with relevant comorbidities, family history, and alarm features.
This information is transformed into a history of present illness (HPI) written in language familiar to clinicians.
AEGIS also supports both the clinician and patient with an individualized "education prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments.
The prescription is created by the portal based on each patient's unique AEGIS "fingerprint."
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of documented alarm symptoms
Time Frame: Completed and documented by the physician in the clinic note within 1 week of the initial clinic visit
|
Prevalence of documented alarm symptoms (blood in the stool, unintentional weight loss, hematochezia, hematemesis) in the clinic note as documented by physicians.
|
Completed and documented by the physician in the clinic note within 1 week of the initial clinic visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of diagnosed organic disease
Time Frame: Organic disease (e.g., Celiac disease, inflammatory bowel disease, etc.) diagnosed within 6 months of the initial clinic visit
|
Organic disease (e.g., Celiac disease, inflammatory bowel disease, etc.) diagnosed within 6 months of the initial clinic visit
|
Time to diagnosis of organic disease
Time Frame: Time to diagnosis of organic disease (e.g., Celiac disease, inflammatory bowel disease, etc.) within 6 months of the initial clinic visit
|
Time to diagnosis of organic disease (e.g., Celiac disease, inflammatory bowel disease, etc.) within 6 months of the initial clinic visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pain
- Neurologic Manifestations
- Signs and Symptoms, Digestive
- Gastrointestinal Diseases
- Pharyngeal Diseases
- Otorhinolaryngologic Diseases
- Intestinal Diseases
- Rectal Diseases
- Esophageal Motility Disorders
- Esophageal Diseases
- Diarrhea
- Gastroesophageal Reflux
- Abdominal Pain
- Deglutition Disorders
- Constipation
- Fecal Incontinence
Other Study ID Numbers
- Pro00045243
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nausea
-
University of North Carolina, Chapel HillNational Institute of Dental and Craniofacial Research (NIDCR)CompletedPost-operative Nausea | Post-operative Vomiting | Nausea PersistentUnited States
-
Cukurova UniversityTarsus UniversityRecruitingNausea, Postoperative | Vomiting, Postoperative | APFEL RİSK SCORETurkey
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
Hoffmann-La RocheCompletedPost-Operative Nausea and VomitingUnited States
-
Cairo UniversityUnknownPost Operative Nausea and VomitingEgypt
-
Yonsei UniversityCompletedPost Operative Nausea and VomitingKorea, Republic of
-
Lancaster General HospitalCompletedBariatric Surgery Candidate | Nausea, PostoperativeUnited States
-
AccentureCompletedPost-Operative Nausea and Vomiting (PONV)Australia
-
Mayo ClinicCompleted
Clinical Trials on AEGIS (Automated Evaluation of Gastrointestinal Symptoms)
-
Cedars-Sinai Medical CenterUniversity of California, Los Angeles; National Institute of Arthritis and... and other collaboratorsCompletedDevelopment and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) PlatformNausea | Abdominal Pain | Constipation | Diarrhea | Gastroesophageal Reflux | Deglutition Disorders | Fecal IncontinenceUnited States
-
Cedars-Sinai Medical CenterUniversity of California, Los AngelesWithdrawnCritical IllnessUnited States
-
CHU de ReimsUnknownSchizophrenia | Bipolar DisorderFrance
-
Fondation Ophtalmologique Adolphe de RothschildRemedee SACompletedParkinson DiseaseFrance
-
Sykehuset Innlandet HFCompleted
-
Central Finland Hospital DistrictUniversity of Eastern FinlandRecruitingArthroplasty Complications | Urinary Retention PostoperativeFinland
-
Shalvata Mental Health CenterUnknownHealthy Subjects | Chronic Cannabis UsersIsrael
-
Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.RecruitingEndometriosis, RectumAustria
-
M.D. Anderson Cancer CenterCompleted
-
IRCCS San RaffaeleCompletedPancreatic Cancer | Diagnosis | InteractionItaly